← Leaderboards
Rick A Bevins
University Of Nebraska Lincoln
$10,365,511
Attributed
$12,459,676
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,852,145 · 13
By mechanism
P20$15,978,681 · 3
R01$8,321,398 · 6
R21$759,648 · 2
U13$648,628 · 1
R03$143,790 · 1
Top collaborators
- Gurudutt Pendyala6 shared
- Sowmya Yelamanchili6 shared
- Konstantin G Kousoulas4 shared
- Joyce Besheer2 shared
Most similar at University Of Nebraska Lincoln
Same institution · by research overlap
- Arthur Andrews$3,605,079
- Jeffrey Smith$685,532
- Laura Acosta$136,852
- Matthew Joseph Gormley$843,770
- Hau Chan$774,551
Others in their field
Top investigators on “Recording Of Previous Events”
- Richard K. Wilson · Washington University$201,137,538
- George R Seage · Abt Associates, Inc.$172,987,660
- Richard A Gibbs · Baylor College Of Medicine$125,425,622
- Muredach P Reilly · Columbia University Health Sciences$88,910,185
- James E. Gern · University Of Wisconsin-Madison$83,174,637
- Lee Marshall Nadler · Dana-Farber Cancer Inst$75,600,198
Research focus
Recording Of Previous EventsPharmaceutical PreparationsResearch PersonnelAffectProgramsRattusChronicAddictionNicotinePre-Clinical ModelLearningBehavioralRelapseExtinction (Psychology)AreaResponseSocietiesConditioningPre-ClinicalDrug UsageStimulusSucroseBiologicalMalignant Neoplasms
Grant awards (50)
Rural Drug Addiction Research (RDAR) Center - Phase 2$2,320,283
P20 · FY2025 · GM · contact PI
Administrative Core$792,024
P20 · FY2025 · GM · contact PI
Understanding and mitigating exacerbated nicotine use resulting from Pavlovianinteroceptive conditioning$359,776
R01 · FY2025 · DA · contact PI
National IDeA Symposium of Biomedical Research Excellence - NISBRE$75,000
U13 · FY2025 · GM
National IDeA Symposium of Biomedical Research Excellence - NISBRE$65,286
U13 · FY2025 · GM
Rural Drug Addiction Research (RDAR) Center - Phase 2$1,793,862
P20 · FY2024 · GM · contact PI
Administrative Core$480,357
P20 · FY2024 · GM · contact PI
National IDeA Symposium of Biomedical Research Excellence - NISBRE$443,056
U13 · FY2024 · GM
Understanding and mitigating exacerbated nicotine use resulting from Pavlovianinteroceptive conditioning$359,776
R01 · FY2024 · DA · contact PI
Rural Drug Addiction Research Center$2,292,634
P20 · FY2023 · GM · contact PI
Administrative Core$762,928
P20 · FY2023 · GM · contact PI
Understanding and mitigating exacerbated nicotine use resulting from Pavlovianinteroceptive conditioning$359,776
R01 · FY2023 · DA · contact PI
National IDeA Symposium of Biomedical Research Excellence - NISBRE$65,286
U13 · FY2023 · GM
Rural Drug Addiction Research Center$2,292,634
P20 · FY2022 · GM · contact PI
Extracellular vesicles, meth relapse and sex differences$473,268
R01 · FY2022 · DA
Interoceptive conditioning with nicotine: Changes in abuse liability$357,244
R01 · FY2022 · DA · contact PI
Extracellular vesicles, meth relapse and sex differences$47,029
R01 · FY2022 · DA
Rural Drug Addiction Research Center$2,329,916
P20 · FY2021 · GM · contact PI
Extracellular vesicles, meth relapse and sex differences$569,253
R01 · FY2021 · DA
Interoceptive conditioning with nicotine: Changes in abuse liability$357,244
R01 · FY2021 · DA · contact PI
Rural Drug Addiction Research Center$2,363,140
P20 · FY2020 · GM · contact PI
Administrative Core$550,903
P20 · FY2020 · GM · contact PI
Extracellular vesicles, meth relapse and sex differences$431,147
R01 · FY2020 · DA
Interoceptive conditioning with nicotine: Changes in abuse liability$357,244
R01 · FY2020 · DA · contact PI
Extracellular vesicles, meth relapse and sex differences$411,529
R01 · FY2019 · DA
Interoceptive conditioning with nicotine: Changes in abuse liability$357,244
R01 · FY2019 · DA · contact PI
Extracellular vesicles, meth relapse and sex differences$407,399
R01 · FY2018 · DA
Interoceptive conditioning with nicotine: Changes in abuse liability$357,244
R01 · FY2018 · DA · contact PI
Interplay between interoception, learning, and drug seeking$183,660
R21 · FY2017 · DA
Pharmacological interventions to diminish nicotine associated responding$287,044
R01 · FY2016 · DA · contact PI
Interplay between interoception, learning, and drug seeking$236,542
R21 · FY2016 · DA
Pharmacological interventions to diminish nicotine associated responding$285,731
R01 · FY2015 · DA · contact PI
Pharmacological interventions to diminish nicotine associated responding$289,370
R01 · FY2014 · DA · contact PI
Pharmacological interventions to diminish nicotine associated responding$277,940
R01 · FY2013 · DA · contact PI
Pharmacological interventions to diminish nicotine associated responding$289,667
R01 · FY2012 · DA · contact PI
Acquired appetitive properties of nicotine$261,162
R01 · FY2010 · DA · contact PI
Acquired appetitive properties of nicotine$272,251
R01 · FY2009 · DA · contact PI
Altering nicotine reward through conditioning$169,682
R21 · FY2009 · DA · contact PI
Altering nicotine reward through conditioning$169,764
R21 · FY2008 · DA · contact PI
Acquired Appetitive Properties of Nicotine$167,646
R01 · FY2008 · DA · contact PI
Acquired Appetitive Properties of Nicotine$171,124
R01 · FY2007 · DA · contact PI
Acquired Appetitive Properties of Nicotine$5,670
R01 · FY2007 · DA · contact PI
Acquired Appetitive Properties of Nicotine$176,294
R01 · FY2006 · DA · contact PI
Reference-dose method and cocaine-conditioned choice$71,040
R03 · FY2006 · DA · contact PI
Acquired Appetitive Properties of Nicotine$180,593
R01 · FY2005 · DA
Reference-dose method and cocaine-conditioned choice$72,750
R03 · FY2005 · DA
Acquired Appetitive Properties of Nicotine$180,044
R01 · FY2004 · DA
PAVLOVIAN CONDITIONING PROCESSES INVOLVING NICOTINE$139,244
R01 · FY2001 · DA
PAVLOVIAN CONDITIONING PROCESSES INVOLVING NICOTINE$105,057
R01 · FY2000 · DA
PAVLOVIAN CONDITIONING PROCESSES INVOLVING NICOTINE$27,388
R01 · FY2000 · DA